title: Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
authors.affiliation: The Proctor & Gamble Co., Cincinnati, Ohio, USA.
authors.forename: J T
authors.initials: JT
authors.lastname: O'Reilly
mesh_terms: D003219:Confidentiality; D018795:Device Approval / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004341:Drug Evaluation / Q000331:legislation & jurisprudence; D004345:Drug Industry; D005060:Europe; D005062:European Union; D006801:Humans; D010330:Patents as Topic; D012106:Research / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration